These 2 Beaten-Down Stocks Are Poised to Bounce Back, Say Analysts
PremiumStock Analysis & IdeasThese 2 Beaten-Down Stocks Are Poised to Bounce Back, Say Analysts
4y ago
Zogenix’s Fintepla Gains FDA Approval, But Analyst Sees Challenging Launch Ahead
Premium
Stock Analysis & Ideas
Zogenix’s Fintepla Gains FDA Approval, But Analyst Sees Challenging Launch Ahead
4y ago
Zogenix Finally Receives FDA Nod For Fintepla, Analysts Bullish On Outlook
Premium
Market News
Zogenix Finally Receives FDA Nod For Fintepla, Analysts Bullish On Outlook
4y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100